A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model

Haemostasis

Volumn 31, Issue 3-6, 2001, Pages 183-191

  Markland, Francis S ^a,b   Shieh, Kate ^a   Zhou, Qing ^a   Golubkov, Vladislav ^a   Sherwin, Russell P ^a   Richters, Valda ^a   Sposto, Richard ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Cancer Research Laboratories   (United States)

Author keywords

Adhesion; Angiogenesis; Animal model; Disintegrin; Integrin; Invasion; Ovarian cancer; Snake venom

Indexed keywords

ANGIOGENESIS INHIBITOR; BLOOD CLOTTING FACTOR 7; CONTORTROSTATIN; DISINTEGRIN; PROTEIN; SNAKE VENOM; SCLEROPROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL ADHESION; CELL LINE; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE STRAIN; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; SNAKE; XENOGRAFT; AGKISTRODON; ANIMAL; CELL CULTURE; CELL MOTION; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; OVARY TUMOR; PATHOLOGY; TRANSPLANTATION;

AGKISTRODON; ANIMALS; CELL ADHESION; CELL MOVEMENT; DISINTEGRINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; SNAKE VENOMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035742117     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048062     Document Type: Article

References (38)

1. Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom
2. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex
3. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors
4. Characterization of the integrin specificities isolated from American pit viper venoms
5. Viper venom disintegrins and related molecules
6. Purification and characterization of platelet aggregation inhibitors from snake venoms
7. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom
8. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis
9. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression
10. Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5
11. Integrins: Versatility, modulation, and signaling in cell adhesion
12. Structural and biologic properties of integrin-mediated cell adhesion
13. Integrins
14. Integrin signaling
15. Experimental model systems of ovarian cancer: Applications to the design and evaluation of new treatment approaches
16. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients
17. Role of the alpha v beta 3 integrin in human melanoma cell invasion
18. Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo
19. Cancer statistics, 1996
20. Tumor angiogenesis: Therapeutic implications
21. Editorial: Angiogenesis and breast cancer
22. Tumor angiogenesis and tissue factor
23. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer
24. The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells
25. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
26. Angiogenesis in primary and metastatic epithelial ovarian carcinoma
27. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: Quantification of endothelial immunoreactivity by image analysis
28. Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies
29. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
30. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits angiogenesis
31. Integrin-mediated adhesion and signalling in ovarian cancer cells
32. RGD-containing peptides inhibit experimental peritoneal seeding of human ovarian cancer cells
33. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis
34. Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo
35. Localization of the alpha 3 beta 1 integrin in some common epithelial tumors of the ovary and in normal equivalents
36. Vascular integrin alpha(v)beta3: A new prognostic indicator in breast cancer
37. Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: Effects of VEGF-toxin conjugate on tumor microvessel density
38. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors